作为治疗剂的雌激素:在创伤中向内皮质病和凝血病
Niruktha Raghavan1, Mira Patel1, Bryan A Cotton2
1The Department of Trauma & Surgical Critical Care, University of Texas Health Science Center San Antonio, San Antonio, Texas, USA.
Transfusion
|February 17, 2026
概括
雌激素通过稳定内皮细胞和帮助血液凝固,在创伤中提供生存优势. 这表明雌激素治疗或使用女性血液产品用于创伤复苏的潜在好处.
科学领域:
- 创伤复苏的复苏治疗方法
- 内皮细胞生物学 内皮细胞生物学
- 凝血科学是一门凝血科学.
背景情况:
- 创伤和失控出血导致高死亡率.
- 创伤诱导的凝血病 (TIC) 是由内皮病引起的,涉及内皮细胞损伤和葡萄糖的降解.
- 目前的复苏策略需要加强,考虑到生物性别差异.
研究的目的:
- 测试雌激素在女性创伤后提供生存优势的假设.
- 探索雌激素在内皮细胞稳定和前凝效应中的双重作用.
- 评估雌激素和女性血液制品在减轻创伤相关凝血病的治疗潜力.
主要方法:
- 文献综述评估雌激素对内皮完整性和血液稳定性的影响.
- 对在手术和重症监护机构中补充雌激素的临床数据的分析.
- 评估雌激素在向内皮病和凝血病中的治疗效用.
主要成果:
- 绝经前女性表现出与雌激醇相关的内在生存优势.
- 雌激素补充剂可以降低出血风险,减少输血需求,改善血静.
- 雌激素有效地向创伤患者的内皮病变和凝血病变.
结论:
- 雌激素在维持内皮完整性和纠正创伤诱导的内皮病变方面发挥着至关重要的作用.
- 雌激素的促凝作用有助于观察到的女性生存优势.
- 用雌激素或女性血液制品针对基于性别的机制是创伤管理的一个有希望的策略.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.0K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.0K
Introduction to Hemostasis
14.9K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
14.9K
Venous Thrombosis III: Interprofessional Care
388
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
388
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
492
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
492
Venous Thrombosis IV: Nursing Management
278
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
278
Extrinsic and Intrinsic Pathways of Hemostasis
13.5K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
13.5K


